Skip to content

Immunovant, Inc. IMVT Book value per share

Book value per share at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$33.20+3.0%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$0.85-22.2%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$9.30-15.0%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$0.70+50.9%
TG Therapeutics logo
TG TherapeuticsTGTX
$3.64+150%
Roivant Sciences logo
Roivant SciencesROIV
$6.52+1.0%

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$7.26B+74.2%
Enterprise value$6.35B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0.0×
Current ratio9.1×-2.1×

Where this comes from

Calculated from Immunovant, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immunovant, Inc.'s book value per share?
Immunovant, Inc. (IMVT) reported book value per share of $4.67 in Q1 2026.
How has Immunovant, Inc.'s book value per share changed year-over-year?
Immunovant, Inc.'s book value per share increased by 0.1% year-over-year, from $4.67 to $4.67.
What is the long-term trend for Immunovant, Inc.'s book value per share?
Over 5 years (2021 to 2026), Immunovant, Inc.'s book value per share has grown at a 0.9% compound annual growth rate (CAGR), from $4.46 to $4.67.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.